Transdermal delivery of combined hormonal contraception: a review of the current literature

The transdermal patch provides an effective and convenient option for hormonal contraception. The patch currently on the US market contains 150 µg norelgestromin and 35 µg ethinylestradiol (EE). The 20 cm(2) patch is applied once weekly for 3 weeks, followed by a patch-free week, for a 21–7 cycle. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Galzote, Rosanna M, Rafie, Sally, Teal, Rachel, Mody, Sheila K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440026/
https://www.ncbi.nlm.nih.gov/pubmed/28553144
http://dx.doi.org/10.2147/IJWH.S102306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440026/
https://www.ncbi.nlm.nih.gov/pubmed/28553144
http://dx.doi.org/10.2147/IJWH.S102306

Ejemplares similares